208 related articles for article (PubMed ID: 20015095)
21. Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD).
Takata Y; Seki S; Dobashi H; Takeshita S; Nakatani K; Kamezawa Y; Hiraide H; Sekine I; Yoshioka S
Clin Exp Immunol; 1998 Nov; 114(2):311-9. PubMed ID: 9822292
[TBL] [Abstract][Full Text] [Related]
22. FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.
Okuzaki D; Ota K; Takatsuki SI; Akiyoshi Y; Naoi K; Yabuta N; Saji T; Nojima H
Sci Rep; 2017 Sep; 7(1):11334. PubMed ID: 28900133
[TBL] [Abstract][Full Text] [Related]
23. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
[TBL] [Abstract][Full Text] [Related]
24. [Serum interleukin-2 receptor in patients with Kawasaki disease].
Matsubara T
Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
[TBL] [Abstract][Full Text] [Related]
25. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.
Wang Z; Xie L; Ding G; Song S; Chen L; Li G; Xia M; Han D; Zheng Y; Liu J; Xiao T; Zhang H; Huang Y; Li Y; Huang M
Nat Commun; 2021 Sep; 12(1):5444. PubMed ID: 34521850
[TBL] [Abstract][Full Text] [Related]
26. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W; Tremoulet AH; Watson VE; Best BM; Shimizu C; Hamilton J; Kanegaye JT; Wei Y; Kao C; Mellis S; Lin C; Burns JC
Hum Immunol; 2010 Sep; 71(9):865-73. PubMed ID: 20600450
[TBL] [Abstract][Full Text] [Related]
27. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
Zhang J; Gui YH; Yang Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the cytokine response in Kawasaki disease.
Eberhard BA; Andersson U; Laxer RM; Rose V; Silverman ED
Pediatr Infect Dis J; 1995 Mar; 14(3):199-203. PubMed ID: 7539120
[TBL] [Abstract][Full Text] [Related]
29. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease.
Takeshita S; Tokutomi T; Kawase H; Nakatani K; Tsujimoto H; Kawamura Y; Sekine I
Clin Exp Immunol; 2001 Aug; 125(2):340-4. PubMed ID: 11529928
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil extracellular trap from Kawasaki disease alter the biologic responses of PBMC.
Jing Y; Ding M; Fu J; Xiao Y; Chen X; Zhang Q
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32808647
[TBL] [Abstract][Full Text] [Related]
31. Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
Nakajima A; Masaki Y; Nakamura T; Kawanami T; Ishigaki Y; Takegami T; Kawano M; Yamada K; Tsukamoto N; Matsui S; Saeki T; Okazaki K; Kamisawa T; Miyashita T; Yakushijin Y; Fujikawa K; Yamamoto M; Hamano H; Origuchi T; Hirata S; Tsuboi H; Sumida T; Morimoto H; Sato T; Iwao H; Miki M; Sakai T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
PLoS One; 2015; 10(5):e0126582. PubMed ID: 25973893
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of plasma SDF-1 and its receptor CXCR4 in peripheral blood mononuclear cells of children with Kawasaki disease].
Zhang J; Gui YH; Yang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):283-6. PubMed ID: 16923357
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
34. Increased serum interleukin-10 level in Kawasaki disease.
Kim DS; Lee HK; Noh GW; Lee SI; Lee KY
Yonsei Med J; 1996 Apr; 37(2):125-30. PubMed ID: 8711935
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease.
Furukawa S; Matsubara T; Motohashi T; Sasai K; Nakachi S; Umezawa Y; Yabuta K
Int Arch Allergy Appl Immunol; 1991; 95(1):7-12. PubMed ID: 1833342
[TBL] [Abstract][Full Text] [Related]
36. CD84 is markedly up-regulated in Kawasaki disease arteriopathy.
Reindel R; Bischof J; Kim KY; Orenstein JM; Soares MB; Baker SC; Shulman ST; Perlman EJ; Lingen MW; Pink AJ; Trevenen C; Rowley AH
Clin Exp Immunol; 2014 Jul; 177(1):203-11. PubMed ID: 24635044
[TBL] [Abstract][Full Text] [Related]
37. Increased levels of circulating soluble CD14 in Kawasaki disease.
Takeshita S; Nakatani K; Tsujimoto H; Kawamura Y; Kawase H; Sekine I
Clin Exp Immunol; 2000 Feb; 119(2):376-81. PubMed ID: 10632678
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease.
Rasouli M; Heidari B; Kalani M
Immunol Lett; 2014 Nov; 162(1 Pt A):269-75. PubMed ID: 25277751
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
Kim HY; Lee HG; Kim DS
J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
[TBL] [Abstract][Full Text] [Related]
40. Gene-expression patterns reveal underlying biological processes in Kawasaki disease.
Popper SJ; Shimizu C; Shike H; Kanegaye JT; Newburger JW; Sundel RP; Brown PO; Burns JC; Relman DA
Genome Biol; 2007; 8(12):R261. PubMed ID: 18067656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
